Skip to main content

VIDEO: “Will I get Alzheimer’s if I live long enough?” with Dr. Maria Corrada

By Commentary, Community Events
Facebook Live Series - ASK THE DOC: Alzheimer's Research Today! This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) the first Friday of every month from 9:00-9:30 AM PST to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Episode 10: "Will I get Alzheimer's if I live long enough?" This month, we're joined by Maria Corrada, ScM, ScD, Professor of Neurology…
Read More

Will I get Alzheimer’s if I live long enough?

By Community Events
Tune in this Friday, November 1 @ 9AM for the next episode of our monthly Facebook LIVE series, "Will I get Alzheimer's if I live long enough?" This month, we're joined by Maria Corrada, ScM, ScD, Professor of Neurology and Epidemiology in the UCI School of Medicine. Dr. Corrada received a masters in Biostatistics and a doctorate in Epidemiology from Johns Hopkins University. She currently serves as co-principal investigator of The 90+ Study, a longitudinal study of aging and dementia in over 1,800 people aged 90 years and older, and Life After 90, a multiethnic cohort of people 90 and older in Northern California. Dr. Corrada's research focuses…
Read More

Biogen’s About Face

By Commentary, In the News
Contributed by Joshua Grill, PhD Yesterday morning, Biogen announced the company’s intention to file with the FDA for approval of Aducanumab, a monoclonal antibody that until recently had been in development as a potential disease-modifying therapy for Alzheimer’s disease. The news came as a shock to us, since two large Phase 3 clinical trials of Aducanumab had been halted for futility earlier in 2019. “Futility” is defined as an early indication that a trial is not likely to demonstrate a drug benefit. As a site for one of those trials, we – along with the research participants and the entire…
Read More

VIDEO: “When should I see a doctor about memory concerns?” with Dr. Malcolm Dick

By Commentary, Community Events
Facebook Live Series - ASK THE DOC: Alzheimer's Research Today! This monthly series features short talks and Q&A with experts from the University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), 1 of 32 congressionally designated Alzheimer’s Disease Research Centers in the nation. Join UCI MIND on Facebook (@UCIrvineMIND) the first Friday of every month from 9:00-9:30 AM PST to learn about advances in research to improve Alzheimer’s disease diagnosis, treatment, and prevention. Episode 9: "When should I see a doctor about memory concerns?" This month, we're joined by UCI MIND Senior Neuropsychologist, Malcolm Dick, PhD.…
Read More